Ontario Construction News staff writer
AtomVie Global Radiopharma Inc. is constructing a purpose-built facility in Hamilton for laboratories, material storage, a decay room, packaging, and shipping area.
The new 64,000 sq. ft. building, leased from Panattoni Development Company, will be completed by 2024 and will enable 10 times more production capacity than AtomVie’s current location, including commercial production.
Within Canada, Hamilton is a nuclear medicine hub, housing key assets, such as specialized hot cell labs and reactors that enable the production of goods that are impossible to produce in most other global jurisdictions.
AtomVie currently ships the radiotherapeutic drugs it is manufacturing to sites in Canada, USA, South America, Europe, Middle-East, Asia and Australia.
“AtomVie is thrilled to announce the execution of its lease agreement with Panattoni Development Company for its future state-of-the-art facility,” said Bruno Paquin, CEO of AtomVie. “The new facility and its strategic location in Hamilton will firm our position as a global leader in the GMP manufacturing and global distribution of radiotherapeutics for both clinical development and the commercial market, and with the outstanding contribution from our staff, to better improve patients’ lives all around the world.”
